Horror movies: The most anticipated coming soon

The horror movies coming soon are shaping up to be the biggest slate in years. After recent hits proved the genre can deliver both box office and awards momentum, studios are doubling down on high-profile titles with major stars and established directors. Audiences tracking late 2026 and 2027 releases now have concrete dates, casts, and creative teams to watch.

Clayface leads DC horror push

DC is entering the R-rated horror lane with a body horror reimagining of the Batman villain. The October 23, 2026 release was moved from September to capitalize on Halloween timing. James Watkins directs from a script by Mike Flanagan.

Tom Rhys Harries stars as Matt Hagen, joined by Naomi Ackie and Max Minghella. Early trailer reactions have focused on the practical effects and grotesque transformation sequences. The project marks DC’s first theatrical swing into this specific horror lane.

Industry observers note that the studio is testing whether established comic properties can support elevated horror without diluting the source material. The move aligns with broader studio interest in adult-skewing genre films that still carry built-in fan bases.

Flanagan returns to exorcist territory

Mike Flanagan’s next major project is The Exorcist: Martyrs, set for March 12, 2027. The film is positioned as a standalone story rather than a direct sequel to the most recent entry. It blends detective procedural elements with supernatural horror.

Scarlett Johansson leads a cast that also includes Chiwetel Ejiofor, Laurence Fishburne, Diane Lane, and John Leguizamo. Early trailer footage emphasizes the serial-killer investigation angle while maintaining the franchise’s core demonic mythology. Flanagan both writes and directs.

Legacy IP plus a high-profile cast has made this the most discussed 2027 horror release in online circles. The project continues Flanagan’s run of expanding prestige horror into studio-scale productions.

Eggers shifts to werewolf folklore

Robert Eggers follows Nosferatu with Werwulf, an original werewolf story set for Christmas Day 2026. Aaron Taylor-Johnson and Lily-Rose Depp star in the Focus Features release. The film continues Eggers’ run of period-set horror rooted in folklore.

Early positioning suggests a continuation of the director’s atmospheric, research-driven approach rather than a commercial pivot. The Christmas date is unusual for horror but consistent with Focus Features’ strategy of counter-programming holiday releases.

Critics and genre fans have cited Eggers’ track record as reason for elevated expectations. The project also benefits from Nosferatu’s recent commercial and critical performance.

Blair Witch revival targets new audience

Lionsgate and Blumhouse are developing an untitled Blair Witch reboot slated for September 24, 2027. Original creators Eduardo Sánchez and Daniel Myrick are attached as producers, along with cast members Joshua Leonard and Michael C. Williams. Chris Thomas Devlin wrote the screenplay.

The project is framed as a new chapter rather than a direct remake. Marketing materials emphasize introducing the found-footage legend to viewers who missed the 1999 original. Dylan Clark, who previously worked in YouTube horror, is directing.

Found-footage nostalgia has been trending in online discussions, and the involvement of the original team is intended to lend authenticity. The release sits within a broader Blumhouse slate that includes both original titles and legacy properties.

Conjuring prequel expands franchise timeline

The Conjuring: First Communion explores the early years of Ed and Lorraine Warren. The September 10, 2027 release stars Garrett Wareing and Amanda Fix as the younger versions of the characters. James Wan and Jason Blum remain involved as producers.

The prequel approach allows the long-running series to continue without requiring the original leads. It also capitalizes on the established fan base that has supported multiple entries across theatrical and streaming windows.

Franchise continuity remains a reliable strategy for studios seeking predictable returns. The project fits within the wider 2027 landscape of legacy horror titles being refreshed for new audiences.

Blumhouse backs original mid-budget titles

Blumhouse Atomic Monster acquired River after strong festival reception, including a 94 percent score on early reviews. The supernatural horror stars Jane Levy and Jessica Rothe. Joshua Giuliano makes his feature debut.

The acquisition followed a strong Midnight Madness screening at TIFF. The company has also set up additional projects such as The Occupant and Sleepover for 2027.

Blumhouse’s continued investment in original titles alongside franchise work reflects confidence in word-of-mouth horror that can scale from festival buzz to wider release. The strategy has proven effective in recent years.

Body horror trend gains momentum

Clayface is the most visible example of body horror moving into studio-backed territory. Trailers have leaned into practical transformation effects rather than heavy CGI. The approach aligns with recent audience interest in visceral, effects-driven sequences.

Online discussion has noted the contrast between Clayface’s commercial positioning and the more elevated tone of Werwulf. Both films are expected to test whether different horror subgenres can coexist in the same release window.

Industry analysts have pointed to Sinners as a turning point that demonstrated horror’s awards potential. That success appears to have emboldened studios to greenlight riskier genre entries.

Release calendar clusters key titles

The late 2026 and 2027 schedule includes multiple high-profile releases spaced across fall and holiday periods. Clayface in October and Werwulf on Christmas Day bookend the 2026 window. 2027 opens with The Exorcist: Martyrs in March before a cluster of September titles.

Studios are clearly aiming for staggered release dates that avoid direct competition while maintaining year-round genre presence. The strategy also accounts for potential delays common in effects-heavy productions.

Exhibition windows remain fluid, but the confirmed dates give marketing teams clear targets for building anticipation through trailers and cast appearances.

Star power drives mainstream interest

Scarlett Johansson’s involvement in The Exorcist: Martyrs has generated mainstream coverage beyond traditional horror outlets. Aaron Taylor-Johnson and Lily-Rose Depp bring similar visibility to Werwulf. The casting strategy reflects studios’ desire to broaden genre appeal.

Established names also help secure premium theatrical real estate and streaming deals. This approach mirrors recent successes where recognizable talent helped horror cross over to general audiences.

Publicists have already begun positioning these films on the awards circuit, citing Sinners as proof that genre recognition can extend beyond box office metrics.

Legacy and original titles share space

The 2026–2027 slate balances franchise revivals with original projects. Clayface and The Exorcist: Martyrs lean on existing IP, while Werwulf and River represent new stories. Blumhouse’s dual strategy allows the company to hedge across both approaches.

Online conversation has focused on whether reboots can successfully introduce classic titles to younger viewers without alienating longtime fans. Early marketing for the Blair Witch project suggests a deliberate middle ground.

The mix of approaches indicates studios are testing multiple paths rather than committing to a single model. Results from the first wave of releases will likely influence 2028 planning.

Anticipation sets stage for next cycle

With confirmed dates, casts, and creative teams now in place, the horror movies coming soon are no longer abstract promises. The combination of franchise familiarity, elevated directors, and star casting has created measurable pre-release interest across platforms. How these films perform will shape studio spending on the genre for years ahead.